Breast Cancer Research Program (BCRP)

Breast Cancer Research Program (BCRP) sits under the Army Medical Research and Development Command's Congressionally Directed Medical Research Programs. It is the oldest CDMRP cancer program, running since 1992, and it received $145 million in FY26 with more than $4.521 billion in cumulative funding through FY25. Its mandate is to push breast cancer research toward earlier prevention, better detection, and lower mortality. BCRP funds grants for universities, nonprofits, research organizations, and for-profit teams. Its challenge framework spans nine overarching problems, including preventing breast cancer, distinguishing deadly from non-deadly disease, and eliminating metastatic mortality. Pre-applications move through eBRAP, with full submissions through Grants.gov, and the program expects applicants to work from the published landscape document rather than a narrow disease subtopic. The program is strongest for proposals that map clearly to one of the stated challenges and can show why the work matters for patient outcomes, not just laboratory novelty. Because it is a flagship congressional cancer line inside CDMRP, it rewards well-formed translational projects that can survive a two-step federal review process and speak to the specific challenge being targeted.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.